Rare diseases
Investigational molecules
Locations
Back to Poland1 804 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PolandStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
PolandStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandStudy on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
PolandStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
PolandStudy on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria
PolandStudy Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
PolandStudy on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler
PolandStudy on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes
PolandStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
